Could a pill replace the needle for edaravone?
NCT ID NCT04493281
First seen Jan 07, 2026 · Last updated Jun 19, 2026 · Updated 22 times
Summary
This study tested whether an oral suspension of edaravone is processed by the body the same way as the IV form. Forty-two healthy Japanese adults received a single dose of each version. The goal was to see if the oral form could be a suitable alternative to the injection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT SUBJECTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational site
Tokyo, Japan
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Edaravone
What this could lead to
If successful, this could support using an oral form of edaravone instead of an IV, making treatment easier for patients.
What could go wrong
This is a small, early-stage trial in healthy volunteers, not patients. It only checks how the drug is processed, not if it works for any disease.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.